Stockreport

Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children [Yahoo! Finance]

Vivos Therapeutics, Inc.  (VVOS) 
PDF On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.'s (NASDAQ: VVOS ) flagship oral medical device, which is used to treat moderate to severe obs [Read more]